S1 Ep1: FDA Approval Insights: Tivozanib in Relapsed/Refractory Advanced RCC

Dr. Rini discusses unique elements of the TIVO-3 trial, the significance of the FDA approval of tivozanib in advanced RCC, and potential next steps for research with the TKI in the paradigm.